BP11126 PLGA 65:35, Lauryl Ester Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa

PLGA 65:35, Lauryl Ester Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa Description

PLGA 65:35, Lauryl Ester Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa is a biodegradable copolymer composed of lactic and glycolic acids in a 65:35 ratio. The lauryl ester termination modulates the degradation kinetics, making it suitable for controlled release and tissue engineering applications. Its defined intrinsic viscosity and molecular weight parameters ensure reproducible performance in processing and end-use scenarios, providing predictable mechanical stability and degradation profiles.

PLGA 65:35, Lauryl Ester Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa Applications

1.         Healthcare Applications
   - Used as a matrix in drug delivery systems to achieve sustained release by leveraging controlled degradation kinetics.
   - Applied as a scaffold material in tissue engineering to support cell proliferation by providing a temporary extracellular matrix.

2.         Industrial Applications
   - Serves as a binder in biodegradable packaging to reduce environmental impact by breaking down under controlled conditions.
   - Utilised in research settings for developing bioresorbable implants, addressing the need for materials that safely degrade in vivo.

PLGA 65:35, Lauryl Ester Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa Packing

The polymer is packaged in an inert, moisture-resistant container to prevent contamination and preserve its physicochemical properties. Each batch is sealed under nitrogen to minimise oxidation and maintain integrity during storage. Protective liners and shock-absorbing materials are used to safeguard the product during transit. Custom packaging solutions are available to meet specific storage and handling requirements.

Additional Information

PLGA polymers are widely investigated for their biodegradability and biocompatibility, making them integral in biomedical research and clinical applications. The ratio of lactic to glycolic acid determines the degradation rate and mechanical properties, which can be finely tuned for various applications such as drug delivery and tissue engineering. Advances in polymer synthesis and processing continue to enhance the performance of these materials in both industrial and healthcare settings.

Understanding the interplay between intrinsic viscosity, molecular weight, and terminal group chemistry is essential for developing reproducible polymeric devices. Researchers benefit from detailed material characterisation, which informs the selection of processing methods and ultimately determines the application performance in regenerative medicine and controlled therapeutic release.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.